EGFR and esophageal squamous cell carcinoma: In ESCC, EGFR CNG assessed by FISH, and/or EGFR protein over-expression have shown promise as predictive biomarkers to identify this benefiting subgroup, but needs prospective validation [3, 7, 12, 13].